510(k) Submission with FDA for FMX314 Surgical Platform

Fortimedix Surgical announced today that it has submitted a premarket notification for the FMX314 Surgical Platform with the US Food and Drug Administration (FDA), under Section 510(k) of the Food, Drug and Cosmetic Act.
Read the full article

Participation SAGES 2015

As part of the pre-commercial marketing effort for our novel platform for single-incision laparoscopic surgery FMX314, Fortimedix Surgical B.V. successfully exhibited at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2015 Annual Meeting (April 15-18) in Nashville, Tennessee.
Read the full article

Note: FMX314 is the engineering code name for symphonX™ used during the pre-commercial phase.

 Download our Media Kit here. For media inquiries, please contact Marc van de Graaf via +1(858) 414 4989 or via our media(at)

Copyright © Fortimedix Surgical 2018. All rights reserved.


Stay updated about the latest developments and innovations from Fortimedix Surgical - subscribe to our newsletter via our subscription form.

By using our website you consent to all cookies in accordance with our Cookie Policy.